oncology
Melanoma

Antibiotics reduce checkpoint inhibitor efficacy

Antibiotics should be avoided where possible in patients receiving checkpoint inhibitor therapy, according to US researchers who found their use was associated with reduced overall survival (OS) in melanoma patients. In what they say is further evidence of the influence of the microbiome on outcomes with immune checkpoint inhibitors, researchers from the University of Pennsylvania ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic